Peter P. Pfreundschuh, Chief Financial Officer at Voyager Therapeutics, Inc. (VYGR), sold 3,764 shares at $7.46 ($28K) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Open-market sale of $28k VYGR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FREQ | SELL | 2022-02-18 | $11K | — | Filing → |
| FREQ | SELL | 2022-02-16 | $6K | — | Filing → |
| URGN | SELL | 2020-10-16 | $52K | — | Filing → |